Letter: Presence of progression or absence of response? Alternative trial designs for immunotherapy of advanced hepatocellular carcinoma. Authors' reply.
Raphael MohrFrank TackeChristoph RoderburgPublished in: Alimentary pharmacology & therapeutics (2024)